BioCentury

7:00 AM GMT, Apr 11, 2011
This article and the information contained in BioCentury's publications and services are solely for your own personal, non-transferable licensed use and cannot be shared with any other individuals. For information about adding subscribers to your account or obtaining article reprints, please contact support@biocentury.com.
Regulatory

Dificid fidaxomicin regulatory update

FDA's Anti-Infective Drugs Advisory Committee voted 13-0 that Dificid fidaxomicin from Optimer was safe and effective at treating

Read the full 181 word article

This article and the information contained in BioCentury's publications and services are solely for your own personal, non-transferable licensed use and cannot be shared with any other individuals. For information about adding subscribers to your account or obtaining article reprints, please contact support@biocentury.com.